Alternative approach to blood screening using the ExaVir reverse transcriptase activity assay

Current HIV Research

Volumn 3, Issue 4, 2005, Pages 371-376

  Seyoum, Elizabeth ^a,c   Wolday, Dawit ^a   Mekonen, Teferi ^d   Girma, Mulu ^a   Meselle, Tsehaynesh ^a   Källander, Clas ^b   Gronowitz, Simon ^b,e   Britton, Sven ^c  

^a Ethio Netherlands AIDS Research Project ENARP   (Ethiopia)

^b Cavidi Tech AB   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ADDIS ABABA UNIVERSITY   (Ethiopia)

^e Biovica AB   (Sweden)

Author keywords

Blood screening; Ethiopia; HIV; Reverse transcriptase; Transfusion security; Viral load

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ADULT; ANTIGEN ANTIBODY COMPLEX; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; ETHIOPIA; FLUOROMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

BLOOD DONORS; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HIV; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 27844459030     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016205774370438     Document Type: Review

References (33)

1. Achkar JM, Burda ST, Konings FA, Urbanski MM, Williams CA, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi PN (2004). Infection With HIV Type 1 Group M Non-B Subtypes in Individuals Living in New York City. Journal of Acquired Immune Deficiency Syndromes. 36: 835-844.
2. Alter HJ, Epstein JS, Swenson SG, VanRaden MJ, Ward JW, Kaslow RA, Menitove JE, Klein HG, Sandler SG, Sayers MH, Hewlett IK, Chernoff AI, and The HIV-Antigen Study Group (1990). Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - an assessment of the efficacy of testing in donor screening. New England Journal of Medicine. 323: 1312-1317.
3. Ayele W, Pollakis G, Abebe A, Fisseha B, Tegbaru B, Tesfaye G, Mengistu Y, Wolday D, van Gemen B, Goudsmit J, Dorigo-Zetsma W, de Baar MP (2004). Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C′ infections in Ethiopia. Journal of Clinical Microbiology. 42: 1534-1541.
4. Bogh M, Machuca R, Gerstoft J, Pedersen C, Obel N, Kvinesdal B, Nielsen H, Nielsen C (2001). Subtype-specific problems with qualitative Amplicor HIV-1 DNA PCR test. Journal of Clinical Virology. 20: 149-153.
5. Braun J, Plantier JC, Hellot MF, Tuaillon E, Gueudin M, Damond F, Malmsten A, Corrigan GE, Simon F (2003). A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS. 17: 331-336.
6. Busch MP (2001). Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed., Blood Safety in the New Millenium. Bethesda: AABB Press.
7. Busch MP, Kleinman SH, Nemo GJ (2003). Current and emerging infectious risks of blood transfusions. JAMA. 289: 959-962.
8. Curran JW, Jaffe HW, Hardy AM, Morgan WM, Selik RM, Dondero TJ (1988). Epidemiology of HIV infection and AIDS in the United States. Science. 239: 610-616.
9. Daar ES, Little S, Pitt J, Santangelo J, Ho P, Harawa N, Kerndt P, Glorgi JV, Bai J, Gaut P, Richman DD, Mandel S, Nichols S (2001). Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Annals of Internal Medicine. 134: 25-29.
10. Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI (2003). Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. Journal of Virology. 77: 5721-5730.
11. Goodnough LT, Shander A, Brecher ME (2003). Transfusion medicine: looking to the future. Lancet. 361: 161-169.
12. Gottesman BS, Grosman Z, Lorber M, Levi I, Shitrit P, Mileguir F, Gottesman O, Chowers MY (2004). Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. Journal of Medical Virology. 73: 167-171.
13. Greengrass VL, Turnball SP, Hocking I, Dunne AL, Tachedjian O, Corrigan GE, Crowe SM (2005). Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. Current HIV Research. 3: 183-190.
14. HIV/AIDS JUNPo (1997). Technical update: blood safety and HIV. Joint United Nations Programme on HIV/AIDS and the Word Health Organisation.
15. Koch WH, Sullivan PS, Roberts C, Francis K, Downing R, Mastro TD, Nkengasong I, Hu D, Masciotra S, Schable C, Lal RB (2001). Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants. Journal of Clinical Microbiology. 39: 1017-1020.
16. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EPt, Petersen LR (1995). Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. New England Journal of Medicine. 333: 1721-1725.
17. Lambert JS, Harris DR, Stiehm ER, Moye J, Jr., Fowler MG, Meyer WA, 3rd, Bethel J, Mofenson LM (2003). Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. 34: 512-519.
18. Laperche S, Maniez-Montreuil M, Courouce AM (2000). Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1. Transfusion clinique et biologique. 7 (suppl. 1): 18s-24s.
19. Ly TD, Edlinger C, Vabret A (2000). Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. Journal of Clinical Microbiology. 38: 2459-2461.
20. Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG (2001). Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. Journal of Clinical Microbiology. 39: 3122-3128.
21. Lyamuya E, Bredberg-Raden U, Albert J, Grankvist O, Msangi V, Kagoma C, Mhalu F, Biberfeld G (1997). Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. Journal of Clinical Microbiology. 35: 278-280.
22. Malmsten A, Shao XW, Aperia K, Corrigan GE, Sandstrom E, Kallander CF, Leitner T, Gronowitz JS (2003). HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. Journal of Medical Virology. 71: 347-359.
23. Malmsten A, Shao XW, Sjödahl S, Fredriksson EL, Pettersson I, Leitner T, Kallander CF, Sandström E, Gronowitz JS (2005). Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. Journal of Medical Virology. 76: 291-296.
24. Marozsan AJ, Fraundorf E, Abraha A, Baird H, Moore D, Troyer R, Nankja I, Arts EJ (2004). Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. Journal of Virology. 78: 11130-11141.
25. Puthanakit T, Apichartpiyakul C, Sirisanthana V (2003). An in house HIV DNA PCR assay for early diagnosis of HIV infection in children in Thailand. Journal of the Medical Association of Thailand. 86: 758-765.
26. Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, Hagos M, Kliphuis A, Pollakis G, Krol A, Geskus R, Miedema F, Goudsmit J, Coutinho R, Fontanet AL (2002). Primary HIV-1 subtype C infection in Ethiopia. Journal of Acquired Immune Deficiency Syndromes. 30: 463-470.
27. Roth WK, Weber M, Seifried E (1999). Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet. 353: 359-363.
28. Sentjens RE, Sisay Y, Vrielink H, Kebede D, Ader HJ, Leckie G, Reesink HW (2002). Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in Ethiopia. Epidemiology and infection. 128: 221-228.
29. Stetler HC, Granade TC, Nunez CA, Meza R, Terrell S, Amador L, George JR (1997). Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS. 11: 369-375.
30. United Nations (1997). Technical update: blood safety and HIV. Joint United Nations Programme on HIV/AIDS and the Word Health Organisation.
31. van Binsbergen J, Siebelink A, Jacobs A, Keur W, Bruynis F, van de Graaf M, van der Heijden J, Kambel D, Toonen J (1999). Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay. Journal of Virological Methods. 82: 77-84.
32. Word Health Organisation (1997). Revised recommendations for the selection and use of HIV antibody tests. Weekly Epidemiological Record. 72: 81-87.
33. Yang Y, Lamendola MH, Mendoza M, Xu D, Nguyen M, Yeh S, Wu Y, Ku J, Rosenstraus M, Sun R (2001). Performance characteristics of the COBAS AmpliScreen HIV-1 test, version 1.5, an assay designed for screening plasma mini-pools. Transfusion. 41: 643-651.